Latest NewsVirginia District Court Rules FDA Unlawfully Restricted Abortion Pill Access ChaseSeptember 12, 2026 A Virginia district court judge ordered the FDA to reconsider its restrictions on mifepristone, a highly safe and effective prescription medication for terminating early pregnancy. The judge, Robert S. Ballou, sided with reproductive health clinics in three states that argued that current restrictions are excessive, medically unnecessary, and inconsistent with federal law. The challenged restrictions are part of FDA’s 2023 risk evaluation mitigation strategy (2023 REMS). Abortion PillsAbortion RightsHealthcareReproductive rightsTelehealthUnited States
